Anti-CARD8 antibody - N-terminal
Be the first to review this product! Submit a review
|
(9 Publications)
Rabbit Polyclonal CARD8 antibody. N-terminal. Suitable for WB and reacts with Human samples. Cited in 9 publications. Immunogen corresponding to Recombinant Fragment Protein within Human CARD8 aa 1-200.
View Alternative Names
DACAR, KIAA0955, NDPP1, CARD8, Caspase recruitment domain-containing protein 8, CARD-inhibitor of NF-kappa-B-activating ligand, Tumor up-regulated CARD-containing antagonist of CASP9, CARDINAL, TUCAN
- WB
Supplier Data
Western blot - Anti-CARD8 antibody - N-terminal (AB194585)
All lanes:
Western blot - Anti-CARD8 antibody - N-terminal (ab194585) at 1/500 dilution
Lane 1:
Extracts from K562 cell line
Lane 2:
Extracts from A673 cell line
Lane 3:
Extracts from ES2 cell line
Predicted band size: 49 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CARD8 serves as a regulatory component in the innate immune system. It belongs to the NLR family and forms part of the inflammasome complex. Inflammasomes are essential for activating pro-inflammatory cytokines like IL-1β. CARD8 modulates the activity of caspase-1 controlling cytokine maturation and secretion. By inhibiting the activation of these pro-inflammatory cytokines CARD8 affects the immune response during infections and inflammatory conditions.
Pathways
CARD8 is involved in both the inflammasome and apoptosis pathways. In the inflammasome pathway CARD8 interacts with proteins like NLRP3 and ASC to regulate caspase-1 activation. In the apoptosis pathway it connects with other proteins like caspase-9 influencing cell death processes. The integration into these pathways highlights CARD8's role in balancing immune response and cell survival.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (9)
Recent publications for all applications. Explore the full list and refine your search
PLoS biology 23:e3003320 PubMed40920844
2025
Applications
Unspecified application
Species
Unspecified reactive species
PLoS pathogens 21:e1013258 PubMed40608794
2025
Applications
Unspecified application
Species
Unspecified reactive species
Science immunology 7:eabm7200 PubMed36332009
2022
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of experimental medicine 219: PubMed36129453
2022
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 298:102032 PubMed35580636
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell reports 33:108264 PubMed33053349
2020
Applications
Unspecified application
Species
Unspecified reactive species
The EMBO journal 39:e105071 PubMed32840892
2020
Applications
Unspecified application
Species
Unspecified reactive species
Life science alliance 3: PubMed32051255
2020
Applications
Unspecified application
Species
Unspecified reactive species
Nature medicine 24:1151-1156 PubMed29967349
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com